Sustaining the HIV and AIDS Response in Grenada: Investment Case BriefHFG Project
The HIV/AIDS program in Grenada is at a turning point, facing both opportunities to expand and target its efforts and threats of decreasing funding. As its National HIV/AIDS Strategic Plan awaits ratification, the country must consider whether and how to implement strategic priorities related to controlling and mitigating the effects of the epidemic. Critical decisions must be made about programming and budgeting for the HIV response in the coming years.
This brief provides analytic inputs to help Grenada develop an “investment case” for its HIV/AIDS program. The Joint United Nations Program on HIV/AIDS (UNAIDS) and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) have encouraged the small-island countries of the eastern Caribbean to develop HIV investment cases, which are reports that aim to help program leaders target investments on the interventions and populations where they will have maximum impact, given limited resources (UNAIDS 2012). The priorities and analysis outlined in this brief will also inform a multi-country regional application to the Global Fund for HIV/AIDS, TB and Malaria.
On-Demand Webinar: Compliance With New Provider Relief Funds Reporting Requir...PYA, P.C.
On September 19, the Department of Health and Human Services (HHS) published its Post-Payment Notice of Reporting Requirements. The Notice details the reporting requirements for all Provider Relief Fund (PRF) recipients that have received $10,000 or more in aggregate payments.
Under the PRF Terms and Conditions, a recipient may use the funds only for healthcare-related expenses and lost revenue attributable to coronavirus. The Notice provides the clearest direction to date regarding permissible uses of PRF funds.
PYA offered a 45-minute complimentary webinar that explained the new reporting requirements and delved into permissible uses. While many questions remain, we provided practical advice on the next steps in the reporting process.
The webinar took place Monday, October 5 at 11 a.m. EDT.
Webinar: Free Money with Strings Attached – Cares Act Considerations for Fron...PYA, P.C.
PYA, in conjunction with the Montana Hospital Association, recently co-hosted a Frontier States Town Hall Meeting webinar, “Free Money With Strings Attached: CARES Act Considerations for Frontier States’ Healthcare Provider Organizations.” Principals Lori Foley, Martie Ross, and David McMillan introduced the CARES Act Provider Relief Fund including distribution formulas, the attestation process, the verification and application process, and ongoing recordkeeping requirement. They also answered attendees’ numerous questions regarding these matters.
Tom Wong: Public Charge: Immigrant Health Under Trump’s New Rulereportingonhealth
Prof. Tom Wong's slides from the Center for Health Journalism webinar, "Public Charge: Immigrant Health Under Trump’s New Rule" 9.11.19
More info: https://www.centerforhealthjournalism.org/content/employee-health-insurance-failing-americans
Sustaining the HIV and AIDS Response in Grenada: Investment Case BriefHFG Project
The HIV/AIDS program in Grenada is at a turning point, facing both opportunities to expand and target its efforts and threats of decreasing funding. As its National HIV/AIDS Strategic Plan awaits ratification, the country must consider whether and how to implement strategic priorities related to controlling and mitigating the effects of the epidemic. Critical decisions must be made about programming and budgeting for the HIV response in the coming years.
This brief provides analytic inputs to help Grenada develop an “investment case” for its HIV/AIDS program. The Joint United Nations Program on HIV/AIDS (UNAIDS) and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) have encouraged the small-island countries of the eastern Caribbean to develop HIV investment cases, which are reports that aim to help program leaders target investments on the interventions and populations where they will have maximum impact, given limited resources (UNAIDS 2012). The priorities and analysis outlined in this brief will also inform a multi-country regional application to the Global Fund for HIV/AIDS, TB and Malaria.
On-Demand Webinar: Compliance With New Provider Relief Funds Reporting Requir...PYA, P.C.
On September 19, the Department of Health and Human Services (HHS) published its Post-Payment Notice of Reporting Requirements. The Notice details the reporting requirements for all Provider Relief Fund (PRF) recipients that have received $10,000 or more in aggregate payments.
Under the PRF Terms and Conditions, a recipient may use the funds only for healthcare-related expenses and lost revenue attributable to coronavirus. The Notice provides the clearest direction to date regarding permissible uses of PRF funds.
PYA offered a 45-minute complimentary webinar that explained the new reporting requirements and delved into permissible uses. While many questions remain, we provided practical advice on the next steps in the reporting process.
The webinar took place Monday, October 5 at 11 a.m. EDT.
Webinar: Free Money with Strings Attached – Cares Act Considerations for Fron...PYA, P.C.
PYA, in conjunction with the Montana Hospital Association, recently co-hosted a Frontier States Town Hall Meeting webinar, “Free Money With Strings Attached: CARES Act Considerations for Frontier States’ Healthcare Provider Organizations.” Principals Lori Foley, Martie Ross, and David McMillan introduced the CARES Act Provider Relief Fund including distribution formulas, the attestation process, the verification and application process, and ongoing recordkeeping requirement. They also answered attendees’ numerous questions regarding these matters.
Tom Wong: Public Charge: Immigrant Health Under Trump’s New Rulereportingonhealth
Prof. Tom Wong's slides from the Center for Health Journalism webinar, "Public Charge: Immigrant Health Under Trump’s New Rule" 9.11.19
More info: https://www.centerforhealthjournalism.org/content/employee-health-insurance-failing-americans
Webinar: “Provider Relief Fund Payments – What We Know, What We Don’t Know, W...PYA, P.C.
The federal government is now making CARES Act Relief Fund payments to Medicare providers. These payments are not loans—they do not have to be repaid or forgiven. However, this money comes with strings attached.
During PYA’s 30-minute webinar, Provider Relief Fund Payments—What We Know, What We Don’t Know, What To Do Now, PYA Principals Martie Ross and Lori Foley discussed:
The source of the funds.
The required attestation process.
Compliance, tax, and audit concerns.
The webinar took place Friday April 17, 2020.
The COVID-19 pandemic has exposed organizational and industry weaknesses. To build a more resilient delivery system, leaders now must engage their governing boards in re-calibrating strategic plans, re-evaluating investments, and re-imagining hospitals’ and health systems’ roles in their communities.
In this 45-minute webinar, PYA Principals Martie Ross and Brian Fuller provided a framework for these critical discussions including root-cause analysis, market assessment, new realities, guiding principles, and strategic and operational priorities.
This webinar originally took place on Wednesday, June 24, 2020.
Webinar: “Got a Payroll? Don’t Leave Money on the Table”PYA, P.C.
Under the CARES Act, every employer with a payroll has an opportunity to retain cash–whether they have a PPP loan or not. What employers need to know right now.
The Coronavirus Aid, Relief, and Economic Security Act (CARES Act) along with the Payroll Protection Program (PPP) offer all business owners relief, but the details can be confusing or overlooked.
Perhaps you don’t fully understand how the deferral of the employer’s share of Social Security taxes works. Maybe you wonder if the deferral even applies to you—good news, it does if you have a payroll!
Failure to fully understand your options could cost you money, at a time when “cash is king.”
As part of PYA’s ongoing commitment to sharing helpful guidance, Tax Principals Debbie Ernsberger and Mark Brumbelow outlined issues and opportunities within the CARES Act, and answered questions during a one-hour webinar that originally aired on Wednesday, May 20, 2020.
LR - Cost And Benefits Of Individual And Family Health Insurance Plans - Nove...eHealth , Inc.
A nationwide perspective on cost and benefits trends in the individual health insurance market based on an analysis of a large, geographically distributed sample of eHealthInsurance purchasers and products.
Webinar: “Trick or Treat? October 22nd Revisions to Provider Relief Fund Repo...PYA, P.C.
On October 22nd, the Department of Health and Human Services released revised Provider Relief Fund (PRF) reporting requirements. Under HHS’ September 19 directive, “lost revenue” was defined narrowly as a negative change in year-over-year patient care operating net income. Now, HHS will permit providers to use PRF funds to cover the difference between their 2019 and 2020 actual patient care revenue with some adjustments for COVID-related expenses. The October 22nd notice is available here.
PYA Principals Martie Ross and Michael Ramey hosted a complimentary 30-minute webinar, “Trick or Treat? October 22nd Revisions to Provider Relief Fund Reporting Requirements” on Thursday, October 29th.
PYA Presented on 2021 E/M Changes and a CARES Act Update During GHA Complianc...PYA, P.C.
The Georgia Hospital Association (GHA) Compliance Officers Roundtable, an active GHA group that meets quarterly and includes educational sessions featuring government representatives, industry experts, and other thought leaders speaking about compliance-related issues, conducted their latest meeting virtually. PYA Principals Lori Foley, Tynan Kugler, and Valerie Rock were among the presenters at this quarter’s event. In their session, they:
Described key elements associated with 2021 E/M changes, and strategies for preparation and implementation.
Explained the impact of 2021 E/M changes on physician compensation and contracting, including potential mitigation approaches.
Presented key components of Stark Law and Anti-Kickback Statute final rules.
Provided an update on the CARES Act.
The Compliance Certification Board offered CEUs for this event, which took place on Friday, December 4, 2020.
This presentation presents the challenges to swing bed reimbursement and discusses swing beds vs. SNFs; readmissions; length of stay; disposition; and transitions of care programs
Since March, PYA experts have closely tracked and carefully evaluated the pandemic’s impact on employed physician compensation. During this complimentary one-hour webinar, PYA Principals Angie Caldwell and Martie Ross highlighted five immediate considerations for hospitals and health systems to manage the storm. They also explored five longer-term considerations impacting future planning.
This webinar took place Friday, July 24, 2020, at 11 a.m. EDT, and was held in conjunction with:
Dallas-Fort Worth Hospital Council
Florida Hospital Association
Kansas Hospital Association
Montana Hospital Association
Sustaining the HIV and AIDS Response in St. Kitts and Nevis: Investment Case ...HFG Project
The HIV/AIDS program in St. Kitts and Nevis is at a turning point, facing both opportunities to expand and target its efforts and threats of decreasing funding. As its National HIV/AIDS Strategic Plan expires in 2014, the country must consider whether and how to revise strategic priorities related to controlling and mitigating the effects of the epidemic. Critical decisions must be made about programming and budgeting for the HIV response in the coming years.
This brief provides analytic inputs to help St. Kitts and Nevis develop an “investment case” for its HIV/AIDS program. UNAIDS and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) have encouraged the small-island countries of the eastern Caribbean to develop HIV investment cases – reports that aim to help program leaders target investments on the interventions and populations where they will have maximum impact, given limited resources (UNAIDS 2012).
Not a surprise to most — healthcare is making headlines on an international level. Though not front and center, still of importance to the hospital community are issues working their way through government agencies and the legislature.
As one of the keynote speakers of this year’s virtual Florida Institute of CPAs Health Care Industry Conference, PYA Senior Manager Kathy Reep presented a “Federal Legislative and Regulatory Update.” She covered a number of current issues affecting healthcare providers, including:
Price transparency.
Congressional action on surprise billing.
The Administration’s budget for 2021.
Medicare proposed rules related to hospital inpatient payments and post-acute care for FY2021.
The virtual event took place June 23-24, 2020.
Webinar: “Provider Relief Fund Payments – What We Know, What We Don’t Know, W...PYA, P.C.
The federal government is now making CARES Act Relief Fund payments to Medicare providers. These payments are not loans—they do not have to be repaid or forgiven. However, this money comes with strings attached.
During PYA’s 30-minute webinar, Provider Relief Fund Payments—What We Know, What We Don’t Know, What To Do Now, PYA Principals Martie Ross and Lori Foley discussed:
The source of the funds.
The required attestation process.
Compliance, tax, and audit concerns.
The webinar took place Friday April 17, 2020.
The COVID-19 pandemic has exposed organizational and industry weaknesses. To build a more resilient delivery system, leaders now must engage their governing boards in re-calibrating strategic plans, re-evaluating investments, and re-imagining hospitals’ and health systems’ roles in their communities.
In this 45-minute webinar, PYA Principals Martie Ross and Brian Fuller provided a framework for these critical discussions including root-cause analysis, market assessment, new realities, guiding principles, and strategic and operational priorities.
This webinar originally took place on Wednesday, June 24, 2020.
Webinar: “Got a Payroll? Don’t Leave Money on the Table”PYA, P.C.
Under the CARES Act, every employer with a payroll has an opportunity to retain cash–whether they have a PPP loan or not. What employers need to know right now.
The Coronavirus Aid, Relief, and Economic Security Act (CARES Act) along with the Payroll Protection Program (PPP) offer all business owners relief, but the details can be confusing or overlooked.
Perhaps you don’t fully understand how the deferral of the employer’s share of Social Security taxes works. Maybe you wonder if the deferral even applies to you—good news, it does if you have a payroll!
Failure to fully understand your options could cost you money, at a time when “cash is king.”
As part of PYA’s ongoing commitment to sharing helpful guidance, Tax Principals Debbie Ernsberger and Mark Brumbelow outlined issues and opportunities within the CARES Act, and answered questions during a one-hour webinar that originally aired on Wednesday, May 20, 2020.
LR - Cost And Benefits Of Individual And Family Health Insurance Plans - Nove...eHealth , Inc.
A nationwide perspective on cost and benefits trends in the individual health insurance market based on an analysis of a large, geographically distributed sample of eHealthInsurance purchasers and products.
Webinar: “Trick or Treat? October 22nd Revisions to Provider Relief Fund Repo...PYA, P.C.
On October 22nd, the Department of Health and Human Services released revised Provider Relief Fund (PRF) reporting requirements. Under HHS’ September 19 directive, “lost revenue” was defined narrowly as a negative change in year-over-year patient care operating net income. Now, HHS will permit providers to use PRF funds to cover the difference between their 2019 and 2020 actual patient care revenue with some adjustments for COVID-related expenses. The October 22nd notice is available here.
PYA Principals Martie Ross and Michael Ramey hosted a complimentary 30-minute webinar, “Trick or Treat? October 22nd Revisions to Provider Relief Fund Reporting Requirements” on Thursday, October 29th.
PYA Presented on 2021 E/M Changes and a CARES Act Update During GHA Complianc...PYA, P.C.
The Georgia Hospital Association (GHA) Compliance Officers Roundtable, an active GHA group that meets quarterly and includes educational sessions featuring government representatives, industry experts, and other thought leaders speaking about compliance-related issues, conducted their latest meeting virtually. PYA Principals Lori Foley, Tynan Kugler, and Valerie Rock were among the presenters at this quarter’s event. In their session, they:
Described key elements associated with 2021 E/M changes, and strategies for preparation and implementation.
Explained the impact of 2021 E/M changes on physician compensation and contracting, including potential mitigation approaches.
Presented key components of Stark Law and Anti-Kickback Statute final rules.
Provided an update on the CARES Act.
The Compliance Certification Board offered CEUs for this event, which took place on Friday, December 4, 2020.
This presentation presents the challenges to swing bed reimbursement and discusses swing beds vs. SNFs; readmissions; length of stay; disposition; and transitions of care programs
Since March, PYA experts have closely tracked and carefully evaluated the pandemic’s impact on employed physician compensation. During this complimentary one-hour webinar, PYA Principals Angie Caldwell and Martie Ross highlighted five immediate considerations for hospitals and health systems to manage the storm. They also explored five longer-term considerations impacting future planning.
This webinar took place Friday, July 24, 2020, at 11 a.m. EDT, and was held in conjunction with:
Dallas-Fort Worth Hospital Council
Florida Hospital Association
Kansas Hospital Association
Montana Hospital Association
Sustaining the HIV and AIDS Response in St. Kitts and Nevis: Investment Case ...HFG Project
The HIV/AIDS program in St. Kitts and Nevis is at a turning point, facing both opportunities to expand and target its efforts and threats of decreasing funding. As its National HIV/AIDS Strategic Plan expires in 2014, the country must consider whether and how to revise strategic priorities related to controlling and mitigating the effects of the epidemic. Critical decisions must be made about programming and budgeting for the HIV response in the coming years.
This brief provides analytic inputs to help St. Kitts and Nevis develop an “investment case” for its HIV/AIDS program. UNAIDS and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) have encouraged the small-island countries of the eastern Caribbean to develop HIV investment cases – reports that aim to help program leaders target investments on the interventions and populations where they will have maximum impact, given limited resources (UNAIDS 2012).
Not a surprise to most — healthcare is making headlines on an international level. Though not front and center, still of importance to the hospital community are issues working their way through government agencies and the legislature.
As one of the keynote speakers of this year’s virtual Florida Institute of CPAs Health Care Industry Conference, PYA Senior Manager Kathy Reep presented a “Federal Legislative and Regulatory Update.” She covered a number of current issues affecting healthcare providers, including:
Price transparency.
Congressional action on surprise billing.
The Administration’s budget for 2021.
Medicare proposed rules related to hospital inpatient payments and post-acute care for FY2021.
The virtual event took place June 23-24, 2020.
US Assistance for International Responses to Zika UWI_Markcomm
Shaping the Caribbean's response to Zika, UWI’s Zika Task Force (www.uwi.edu/zika) is gathering and providing expert advice to develop a strategic, scientific approach for tackling the Zika virus.
CRFB Webinar - The COVID-19 Economic Crisis, the Federal Response, and Our Ri...CRFBGraphics
This brief presentation contains a number of charts and other visualizations that help make sense of our nation’s fiscal state prior to the onset of the pandemic, the nature and scale of the current economic crisis, how the Federal Government has responded thus far, and the future implications of that response for the federal budget, deficit and debt.
Universal coverage of essential health services in sub Saharan Africa: projec...HFG Project
The first decade of the new millennium brought high-level advocacy to mobilize more funding for health coupled with unprecedented economic growth in some African countries. Given the region’s healthy economic outlook, will countries have adequate domestic resources for basic health services by 2020? USAID’s Health Finance and Governance project looked into sub-Saharan Africa’s health financing outlook by projecting domestic health spending per capita to 2020 and comparing it to an internationally-accepted target ($60 per capita) for universal coverage of a package of essential health services. The analysis modeled two assumptions: 1) domestic health spending continuing to increase in line with current economic growth and 2) countries moving aggressively towards fulfilling their Abuja commitment (15% of the government expenditure). Under the economic growth assumption alone, the projections indicate that a little over half of the countries will be spending over USD 60 per capita by 2020. In this presentation, Dr. Carlos Avila discussed the results of the analysis and reaffirmed the need for complementary actions to improve equity and efficiency in addition to resource mobilization.
Town Hall Meeting, hosted by Congressman Jim Moran, Alexandria, VA July 28, 2008
Presented by:
David M. Walker, President and CEO, The Peter G. Peterson Foundation and Former Comptroller General of the United States
This presentation explains how much the federal government spends on the major health care programs: Medicare, Medicaid, the Children’s Health Insurance Program, and marketplace subsidies and related expenditures. In 2018, about 155 million people were enrolled in those programs. CBO projects that net outlays for the programs will grow from about $1.0 trillion in 2018 to about $2.0 trillion in 2028.
Presentation by Jessica Banthin, Deputy Assistant Director in CBO’s Health, Retirement, and Long-Term Analysis Division, at the Alliance for Health Policy Summit on Health Care Costs in America.
Hfg barbados costing community hiv final reportHFG Project
Barbados is currently experiencing tight fiscal constraints due to the slowdown of economic growth coupled with the fact that as a high-income country, it now no longer qualifies for concessional loan arrangements and grants from development partners. The President’s Emergency Plan for AIDS Relief (PEPFAR) has indicated a plan to reduce, and eventually cease, funding for HIV programs in Barbados, within the next two years. Given the current funding environment, the Ministry of Health and Wellness is looking for ways to continue financing the program through improved efficiency and by making evidence-based investments into cost-effective interventions. They are also seeking ways to identify new approaches to financing, which will allow continued health coverage and maintain the gains seen in the sector.
Civil society organizations (CSOs) began offering community-level HIV interventions in 2017, including testing, treatment, and social support to key populations. Some of these populations are highly stigmatized, so community outreach is perceived as necessary. Community-based services are expected to result in improved outcomes for these populations (e.g., reduced loss to follow-up and higher retention in care, improved adherence to treatment). This outreach could be particularly valuable in supporting the government’s adoption of the WHO-recommended Treat All strategy by helping to link persons living with HIV (PLHIV) to treatment and promote adherence.
This study assesses the cost of HIV-related services provision at the CSO level. It aims to benefit both the CSOs themselves and the government of Barbados. The government will be able to consider the results in deciding whether or how to allocate funds to CSOs to enable the CSOs to provide some key services when PEPFAR funding ceases. This study is one of several HFG activities implemented in four countries in the Caribbean to prepare the countries for donor transition.
Donor Government Disbursements for Family Planning in 2017 (Slideshow)KFF
Donor government funding for family planning increased in 2017, rising from $1.20 billion in 2016 to $1.27 billion (an increase of $74 million or 6%, as measured in current terms); funding increased even after accounting for inflation and currency fluctuations.
2019 KFF Employer Health Benefits Survey ChartpackKFF
The 2019 Employer Health Benefits Survey finds annual family premiums for employer health insurance rose 5% to average $20,576 this year. On average, workers pay $6,015 toward the cost.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
U.S.Global Health Funding, FY 2006 - 2020 Request
1. NOTES: Represents total known funding provided through the State Department, USAID, CDC, NIH, and DoD. FY13 includes the effects of sequestration.
FY18, FY19, and FY20 Request are preliminary estimates. Some global health funding that is not specified in the appropriations bills and is determined at the
agency level is not yet known for FY18, FY19, and the FY20 Request and is assumed to remain at prior year levels.
SOURCE: Kaiser Family Foundation analysis of data from the “Consolidated Appropriations Act, 2019” (P.L. 116-6) and accompanying explanatory reports,
the Office of Management and Budget, and U.S. Foreign Assistance Dashboard.
U.S. Global Health Funding, FY 2006 – FY 2020 Request
$5.4
$6.7
$8.5
$9.4
$10.3
$10.0 $10.1
$9.8
$10.5
$11.4
$10.5 $10.7 $10.8 $11.0
$8.0
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
In Billions
2. NOTES: Total federal budget figure is an estimate only. Global Health represents total known funding provided through the State Department, USAID, CDC,
NIH, and DoD.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Congressional Budget Office, and Agency Congressional
Budget Justifications.
U.S. Global Health Funding as a Share of the
Federal Budget, FY 2020 Request
Global Health
$8.0 billion
<1%
3. NOTES: Represents total known funding (base and supplemental) provided through the State Department, USAID, CDC, NIH, and DoD. HIV includes funding through
State/OGAC, USAID, CDC, NIH, and DoD. Malaria includes funding through USAID, CDC, NIH, and DoD. TB, Nutrition, NTDs, and Vulnerable Children include funding through
USAID. MCH includes funding through USAID and CDC as well as contributions to UNICEF. FP/RH includes funding through USAID as well as contributions to UNFPA. Global
Health Security includes funding through USAID, CDC, and DoD, as well as emergency Ebola and Zika funding. “Other” includes funding through USAID, CDC, and NIH as well
as contributions to WHO and PAHO and the Emergency Reserve Fund. Some global health funding in the FY20 Request is not yet known (e.g. CDC funding for malaria) and is
estimated based on prior year levels.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations
Bills, and U.S. Foreign Assistance Dashboard [website], available at: www.foreignassistance.gov.
U.S. Global Health Funding, By Sector, FY 2020 Request
HIV
$3,931
49%
Global Fund
$958
12%
MCH
$901
11%
Malaria
$871
11%
Global Health Security
$482
6%
TB
$262
4%
FP/RH
$259
3%
Nutrition
$90
1%
NTDs
$75
1%
Vulnerable Children
$0
0%
Other
$176
2%
In Millions
Total = $8.0 billion
4. NOTES: Represents total known funding (base and supplemental) provided through the State Department, USAID, CDC, NIH, and DoD. FY19 is based on funding provided in the “Consolidated
Appropriations Act, 2019” (P.L. 116-6) and is a preliminary estimate. HIV includes funding through State/OGAC, USAID, CDC, NIH, and DoD. Malaria includes funding through USAID, CDC, NIH, and
DoD. TB, Nutrition, NTDs, and Vulnerable Children include funding through USAID. MCH includes funding through USAID and CDC as well as contributions to UNICEF. FP/RH includes funding through
USAID as well as contributions to UNFPA. Global Health Security includes funding through USAID, CDC, and DoD, as well as emergency Ebola and Zika funding. “Other” includes funding through USAID,
CDC, and NIH as well as contributions to WHO and PAHO and the Emergency Reserve Fund. Some global health funding is not yet known for FY19 and the FY20 Request (e.g. CDC funding for malaria)
and is estimated based on prior year levels.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations Bills, and U.S. Foreign
Assistance Dashboard [website], available at: www.foreignassistance.gov.
U.S. Global Health Funding, Percent Change by
Sector, FY 2019 – FY 2020 Request
-100%
(-$24)
-57%
(-$342)
-39%
(-$110)
-38%
(-$44)
-29%
(-$392)
-28%
(-1496)
-27%
(-28)
-26%
(-313)
-14%
(-44)
-12%
(-113)
-4%
(-21)
Vunerable
Children FP/RH Other Nutrition
Global
Fund HIV NTDs MCH TB Malaria
Global
Health
Security
In Millions
5. NOTES: Represents total known funding (base and supplemental) provided through the State Department, USAID, CDC, NIH, and DoD. HIV includes funding through State/OGAC, USAID, CDC, NIH, and
DoD. Malaria includes funding through USAID, CDC, NIH, and DoD. TB, Nutrition, NTDs, and Vulnerable Children include funding through USAID. MCH includes funding through USAID and CDC as well
as contributions to UNICEF (the FY20 request proposes to eliminate the IO&P account which includes the U.S. contribution to UNICEF). FP/RH includes funding through USAID as well as contributions to
UNFPA. Global Health Security includes funding through USAID, CDC, and DoD, as well as emergency Ebola and Zika funding. “Other” includes funding through USAID, CDC, and NIH as well as
contributions to WHO and PAHO and the Emergency Reserve Fund. Some global health funding is not yet known for FY18 and the FY20 Request (e.g. CDC funding for malaria) and is estimated based on
prior year levels.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations Bills, and U.S. Foreign
Assistance Dashboard [website], available at: www.foreignassistance.gov.
U.S. Global Health Funding, By Sector, FY 2006 –
FY 2020 Request
$297 $254 $301 $284 $290 $293 $319 $176
$390 $376 $486 $390 $499 $552 $512 $482
$545 $840
$1,050 $1,300
$1,650 $1,350 $1,350
$958
$2,651
$5,028
$5,574 $5,125
$4,940 $5,218 $5,351
$3,931$94
$163
$249
$256
$243 $240 $265
$262
$226
$522
$755
$812
$862 $873
$974
$871
$13
$15
$15
$18
$22
$22
$23
$0
$15
$15
$65 $89
$100
$100
$100
$75
$425
$471
$715
$638
$622 $604
$608
$259
$728
$846
$1,046
$1,157
$1,287 $1,280
$1,334
$991
$5,381
$8,530
$10,255 $10,069
$10,515 $10,532
$10,836
$8,005
2006 2008 2010 2012 2014 2016 2018 2020 Request
MCH/Nutrition
FP/RH
NTDs
Vulnerable Children
Malaria
TB
HIV
Global Fund
Global Health Security
Other
In Millions
6. NOTES: Represents total known funding (base and supplemental) provided through the State Department, USAID, CDC, NIH, and DoD. HIV includes funding through State/OGAC, USAID, CDC, NIH, and DoD. Malaria
includes funding through USAID, CDC, NIH, and DoD. TB, Nutrition, NTDs, and Vulnerable Children include funding through USAID. MCH includes funding through USAID and CDC as well as contributions to UNICEF.
FP/RH includes funding through USAID as well as contributions to UNFPA. Global Health Security includes funding through USAID, CDC, and DoD, as well as emergency Ebola and Zika funding. “Other” includes funding
through USAID, CDC, and NIH as well as contributions to WHO and PAHO and the Emergency Reserve Fund. Some global health funding is not yet known for FY18 and the FY20 Request (e.g. CDC funding for malaria)
and estimated based on prior year levels.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations Bills, and U.S. Foreign Assistance Dashboard
[website], available at: www.foreignassistance.gov.
Share of U.S. Global Health Funding, By Sector,
FY 2006 – FY 2020 Request
6% 3% 3% 3% 3% 3% 3% 2%
7%
4% 5% 4% 5% 5% 5% 6%
10%
10% 10% 13%
16% 13% 12% 12%
49% 59% 54% 51% 47% 50% 49% 49%
2%
2%
2%
3% 2% 2% 2% 3%
4%
6%
7% 8% 8% 8% 9% 11%
<1%
<1% <1% <1% <1% <1% <1%
0%
<1%
<1%
1%
1% 1% 1%
1% 1%
8%
6% 7% 6% 6% 6% 6% 3%
14%
10% 10% 11% 12% 12% 12% 12%
2006 2008 2010 2012 2014 2016 2018 2020
Request
MCH/Nutrition
FP/RH
NTDs
Vulnerable Children
Malaria
TB
HIV
Global Fund
Global Health Security
Other
7. NOTES: Represents total known funding (base and supplemental) provided through the State Department, USAID, CDC, NIH, and DoD. FY19 is based on funding provided in the “Consolidated
Appropriations Act, 2019” (P.L. 116-6) and is a preliminary estimate. HIV includes funding through State/OGAC, USAID, CDC, NIH, and DoD. Malaria includes funding through USAID, CDC, NIH, and
DoD. TB, Nutrition, NTDs, and Vulnerable Children include funding through USAID. MCH includes funding through USAID and CDC as well as contributions to UNICEF. FP/RH includes funding through
USAID as well as contributions to UNFPA. Global Health Security includes funding through USAID, CDC, and DoD, as well as emergency Ebola and Zika funding. “Other” includes funding through USAID,
CDC, and NIH as well as contributions to WHO and PAHO and the Emergency Reserve Fund. Some FY18, FY19, and FY20 Request global health is not yet known (e.g. CDC funding for malaria) and is
estimated based on prior year levels.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations Bills, and U.S. Foreign
Assistance Dashboard [website], available at: www.foreignassistance.gov.
Distribution of U.S. Global Health Funding, By
Sector, FY 2006 – FY 2020 Request
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
Other
Vulnerable Children
NTDs
Global Health Security
TB
FP/RH
Malaria
Global Fund
MCH/Nutrition
HIV
8. NOTES: Represents total known funding (base and supplemental) provided through the State Department, USAID, CDC, NIH, and DoD. FY13 includes the effects of sequestration. FY19 is based on
funding provided in the “Consolidated Appropriations Act, 2019” (P.L. 116-6) and is a preliminary estimate. Some funding provided through Economic Support Fund (ESF) and Development Assistance
(DA) accounts is not yet known for FY18, FY19 and the FY20 Request and is assumed to remain at prior year levels. Multilateral funding includes the Global Fund, GAVI, UNAIDS, UNICEF, UNFPA,
WHO, PAHO, and the Global TB Drug Facility. Several international organizations (including UNICEF, UNAIDS, and others) that have historically received specified funding amounts in the budget are not
allocated any funding in the FY 2020 Request. While it is possible that the Administration could provide funding to these organizations, such funding would have to be taken from either bilateral programs
or other accounts.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations Bills, and U.S. Foreign
Assistance Dashboard [website], available at: www.foreignassistance.gov.
Bilateral & Multilateral Share of U.S. Global Health
Funding, FY 2009 – FY 2020 Request
84% 85% 85% 82% 79% 79% 83% 81% 81% 81% 82% 84%
16% 15% 15% 18% 21% 21% 17% 19% 19% 19% 18% 16%
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
Multilateral
Bilateral
In Billions
$9.4 $10.3 $10.7$10.0 $10.1 $9.8 $10.5 $11.4 $10.5 $10.8 $11.0 $8.0
9. NOTES: Represents total known funding (base and supplemental) provided through the State Department, USAID, CDC, NIH, and DoD. Includes Global Fund
appropriations provided through State, USAID, and NIH. State includes contributions to UNICEF, UNFPA, WHO, and PAHO. Some global health funding for
FY18 and the FY20 Request is not yet known (e.g. CDC funding for malaria) and estimated based on prior year levels.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional
Appropriations Bills, and U.S. Foreign Assistance Dashboard [website], available at: www.foreignassistance.gov.
Share of U.S. Global Health Funding, By Agency,
FY 2006 – FY 2020 Request
42%
58% 56% 58% 57% 57% 55% 55%
37%
25% 29%
29% 29% 30% 30%
27%
7%
4% 3%
4% 4% 4% 5%
6%
12% 11% 10% 6% 7% 7% 8% 9%
3% 3% 3% 3% 4% 3% 2% 3%
2006 2008 2010 2012 2014 2016 2018 2020
Request
DoD
NIH
CDC
USAID
State
$5.4b $8.5b $10.3b $10.1b $10.5b $10.5b $10.8b $8.0b
10. NOTES: PEPFAR was created in 2003 and funding began in FY04. PEPFAR includes funding for HIV, TB, and the Global Fund to Fight AIDS, Tuberculosis and Malaria. HIV
includes funding through State/OGAC, USAID, CDC, NIH, and DoD. TB includes funding provided through USAID. Global Fund includes contributions provided through the State
Department, USAID, and NIH. FY13 includes the effects of sequestration. FY19 is based on funding provided in the “Consolidated Appropriations Act, 2019” (P.L. 116-6) and is a
preliminary estimate. Some funding for HIV programs through the Economic Support Fund (ESF) account at USAID is not yet known for FY18, FY19, and the FY20 Request and
is assumed to remain at prior year levels.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations
Bills, and U.S. Foreign Assistance Dashboard [website], available at: www.foreignassistance.gov.
U.S. Funding for the President’s Emergency Plan for
AIDS Relief (PEPFAR), FY 2004 – FY 2020 Request
$1,643
$2,263
$2,651
$3,700
$5,028
$5,488 $5,574 $5,440
$5,125
$4,709 $4,940
$5,220 $5,218 $5,320 $5,351 $5,427
$3,931
$87
$94
$94
$95
$163
$177 $249
$238
$256
$232
$243
$242 $240 $244 $265 $306
$262
$547
$347
$545
$724
$840
$1,000
$1,050
$1,046
$1,300
$1,569
$1,650
$1,350 $1,350 $1,350 $1,350 $1,350
$958
$2,277
$2,705
$3,289
$4,519
$6,031
$6,664
$6,873
$6,724 $6,681
$6,511
$6,833 $6,813 $6,808 $6,914 $6,966 $7,083
$5,151
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
Global Fund
TB
HIV
In Millions
11. NOTES: Includes HIV funding provided through State/OGAC, USAID, CDC, NIH, and DoD. Bilateral HIV includes funding for UNAIDS, IAVI, the Commodity Fund, and
Microbicides research activities. Includes base and supplemental funding. FY13 includes the effects of sequestration. FY19 is based on funding provided in the “Consolidated
Appropriations Act, 2019” (P.L. 116-6) and is a preliminary estimate. Some funding for HIV programs provided through the Economic Support Fund (ESF) account at USAID is
not yet known for FY18, FY19, and the FY20 Request and is assumed to remain at prior year levels.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations
Bills, and U.S. Foreign Assistance Dashboard [website], available at: www.foreignassistance.gov.
U.S. Funding for Bilateral HIV, FY 2001 – FY 2020
Request
$603
$835
$1,101
$1,643
$2,263
$2,651
$3,700
$5,028
$5,488 $5,574
$5,440
$5,125
$4,709
$4,940
$5,220 $5,218
$5,320 $5,351 $5,427
$3,931
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
In Millions
12. NOTES: Includes TB funding provided through USAID. Bilateral TB includes funding for the Global TB Drug Facility. Includes base and supplemental funding. FY13 includes the
effects of sequestration. FY19 is based on funding provided in the “Consolidated Appropriations Act, 2019” (P.L. 116-6) and is a preliminary estimate. Some funding for TB
programs provided through the Economic Support Fund (ESF) account at USAID is not yet known for FY19 and the FY20 Request and is assumed to remain at prior year levels.
Totals do not include global TB funding provided by the CDC through a transfer from the “HIV/AIDS, Viral Hepatitis, STI and TB Prevention” account.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations
Bills, and U.S. Foreign Assistance Dashboard [website], available at: www.foreignassistance.gov.
U.S. Funding for Global Tuberculosis (TB),
FY 2001 – FY 2020 Request
$64
$74 $79
$87
$94 $94 $95
$163
$177
$249
$238
$256
$232
$243 $242 $240 $244
$265
$306
$262
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
In Millions
13. NOTES: Includes malaria funding provided through USAID, CDC, NIH, and DoD. Includes base and supplemental funding. FY13 includes the effects of sequestration. FY19 is
based on funding provided in the “Consolidated Appropriations Act, 2019” (P.L. 116-6) and is a preliminary estimate. Some funding for malaria programs at CDC is not yet known
for FY18, FY19, and the FY20 Request and is assumed to remain at prior year levels.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations
Bills, and U.S. Foreign Assistance Dashboard [website], available at: www.foreignassistance.gov.
U.S. Funding for Global Malaria, FY 2001 –
FY 2020 Request
In Millions
$146
$171 $165
$198 $214 $226
$398
$522 $535
$755
$800 $812 $822
$862 $854 $873
$963 $974 $984
$871
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
14. NOTES: : Includes Global Fund contributions provided through the State Department, USAID, and NIH. Includes base and supplemental funding. FY13 includes the effects of
sequestration. FY19 is based on funding provided in the “Consolidated Appropriations Act, 2019” (P.L. 116-6) and is a preliminary estimate.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations
Bills, and U.S. Foreign Assistance Dashboard [website], available at: www.foreignassistance.gov.
U.S. Funding for The Global Fund, FY 2001 –
FY 2020 Request
$100
$175
$347
$547
$347
$545
$724
$840
$1,000
$1,050 $1,046
$1,300
$1,569
$1,650
$1,350 $1,350 $1,350 $1,350 $1,350
$958
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
In Millions
15. U.S. Funding for Global Neglected Tropical
Diseases (NTDs), FY 2006 – FY 2020 Request
NOTES: Includes NTD funding provided through USAID. Includes base and supplemental funding. FY13 includes the effects of sequestration. FY19 is based on funding provided
in the “Consolidated Appropriations Act, 2019” (P.L. 116-6) and is a preliminary estimate.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations
Bills, and U.S. Foreign Assistance Dashboard [website], available at: www.foreignassistance.gov.
$15 $15 $15
$25
$65
$77
$89
$86
$100 $100 $100 $100 $100
$103
$75
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
In Millions
16. NOTES: Includes MCH and nutrition funding provided through USAID and CDC as well as U.S. contributions to UNICEF. Prior to FY09, nutrition funding was included as part of MCH. Does
not include funding provided through Food for Peace (FFP) due to the unique nature of the program. Includes base and supplemental funding. FY13 includes the effects of sequestration. FY19
is based on funding provided in the “Consolidated Appropriations Act, 2019” (P.L. 116-6) and is a preliminary estimate. Some MCH and nutrition funding is determined at the agency level and
is not yet known for FY19; for comparison purposes, these amounts are assumed to remain at prior year levels. Several international organizations (including UNICEF, UNAIDS, microbicides
research, IAVI, and others) that have historically received specified funding amounts in the budget are not allocated any funding in the FY 2020 Request. While it is possible that the
Administration could provide funding to these organizations, such funding would have to be taken from either bilateral programs or other accounts.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations Bills, and U.S.
Foreign Assistance Dashboard [website], available at: www.foreignassistance.gov.
U.S. Funding for Maternal & Child Health (MCH)
and Nutrition, FY 2006 – FY 2020 Request
$728 $694
$846 $872
$939 $974
$1,060 $1,037
$1,147 $1,176 $1,136
$1,235 $1,209 $1,214
$901
$55
$107 $93
$97 $97
$140 $139
$144
$148
$125 $145
$90
$728
$694
$846
$927
$1,046 $1,067
$1,157 $1,134
$1,287 $1,315
$1,280
$1,383
$1,334 $1,359
$991
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
Nutrition
MCH
In Millions
17. NOTES: Includes FP/RH funding through USAID as well as U.S. contributions to UNFPA. Includes base and supplemental funding. FY13 includes the effects of sequestration.
FY19 is based on funding provided in the “Consolidated Appropriations Act, 2019” (P.L. 116-6) and is a preliminary estimate.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations
Bills, and U.S. Foreign Assistance Dashboard [website], available at: www.foreignassistance.gov.
U.S. Funding for International Family Planning/
Reproductive Health (FP/RH), FY 2006 – FY 2020 Request
$425
$451
$471
$552
$715
$633 $638
$615 $622 $622
$604 $608 $608 $608
$259
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
In Millions
18. $909
$100 $38$146$390
$321
$376
$417
$486
$397 $390 $366
$499
$1,342
$552
$364
$512 $504 $482
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
Emergency Zika
Emergency Ebola
NOTES: Includes Global Health Security funding through USAID and CDC. Totals include base and supplemental funding. FY13 includes the effects of sequestration. FY19 is
based on funding provided in the “Consolidated Appropriations Act, 2019” (P.L. 116-6) and is a preliminary estimate. FY20 Request funding for GEIS at DoD is not yet known and
is assumed to remain at prior year request levels. In FY15, Congress provided $5.4 billion in emergency funding to address the Ebola outbreak, of which $909.0 million was
specifically designated for global health security. In FY16, Congress provided $1.1 billion in emergency funding to address the Zika outbreak, of which $145.5 million was
specifically designated for global health security. In FY18, Congress provided $100 million in unspent Emergency Ebola funding for “programs to accelerate the capabilities of
targeted countries to prevent, detect, and respond to infectious disease outbreaks.” In FY19, Congress provided $38 million in unspent Emergency Ebola funding for “programs
to accelerate the capacities of targeted countries to prevent, detect, and respond to infectious disease outbreaks.”
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional Appropriations
Bills, and U.S. Foreign Assistance Dashboard [website], available at: www.foreignassistance.gov, GEIS and AFHSC/AFHSB annual reports, communication with GEIS personnel,
and IOM, Review of the DoD-GEIS Influenza Programs: Strengthening Global Surveillance and Response, 2008.
U.S. Funding for Global Health Security, FY 2006-
FY 2020 Request
In Millions
19. NOTES: Includes polio funding provided through the CDC‘s global immunization program and the Global Health Programs (GHP) and Economic Support Fund
(ESF) accounts at USAID. FY13 includes the effects of sequestration. FY19 is based on funding provided in the “Consolidated Appropriations Act, 2019” (P.L.
116-6) and is a preliminary estimate. Totals may not sum due to rounding.
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional
Appropriations Bills, and U.S. Foreign Assistance Dashboard website, www.foreignassistance.gov.
U.S. Funding for Global Polio, By Agency,
FY 2009 – FY 2020 Request
$102 $102 $102
$116 $110
$151 $159
$169 $174 $176 $176
$165
$32 $34 $32
$40 $44
$59
$59
$59
$59 $59 $59
$23
$134 $136 $134
$155 $154
$210
$218
$228
$233 $235 $235
$188
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
USAID
CDC
In Millions
20. NOTES: FY13 includes the effects of sequestration. Due to policy conditions put in place by Congress, actual annual contributions are frequently lower than
enacted levels (e.g. in each of the years between 2002-2008 and 2017-2019, Congress approved funding for UNFPA, however, the administrations during
those periods invoked the Kemp-Kasten Amendment to withhold this funding).
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional
Appropriations Bills, and U.S. Foreign Assistance Dashboard [website], available at: www.foreignassistance.gov
U.S. Funding (Enacted) for the United Nations
Population Fund (UNFPA), FY 2001 – FY 2020 Request
$25
$34 $34 $34 $34 $34 $34
$40
$50
$55
$40
$35
$33
$35 $35 $35
$33 $33 $33
$0
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
In Millions
21. NOTES: FY13 includes the effects of sequestration. FY19 is a preliminary estimate. Due to policy conditions put in place by Congress, actual annual
contributions are frequently lower than enacted levels (e.g. in each of the years between 2002-2008 and 2017-2019, Congress approved funding for UNFPA,
however, the administrations during those periods invoked the Kemp-Kasten Amendment to withhold this funding).
SOURCE: Kaiser Family Foundation analysis of data from the Office of Management and Budget, Agency Congressional Budget Justifications, Congressional
Appropriations Bills, and U.S. Foreign Assistance Dashboard [website], available at: www.foreignassistance.gov.
U.S. Funding (Actual) for the United Nations Population
Fund (UNFPA), FY 2001 – FY 2020 Request
$22
$0 $0 $0 $0 $0 $0 $0
$46
$51
$37
$30
$29
$31 $31 $31
$0 $0 $0 $0
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Request
In Millions